Neuroscientists are mining nucleic acids, fluids, and brain images for biomarkers of risk of brain disorders. This book brings clarity to several debates on the neuroethics of biomarkers by arguing for the abandonment of a categorical concept of disorder (sick vs. well) and the adoption of an explicitly probabilistic one.
Neuroscientists are mining nucleic acids, fluids, and brain images for biomarkers of risk of brain disorders. This book brings clarity to several debates on the neuroethics of biomarkers by arguing for the abandonment of a categorical concept of disorder (sick vs. well) and the adoption of an explicitly probabilistic one.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Matthew L. Baum, DPhil, is an MD-PhD trainee at Harvard & MIT within the Division of Health Sciences & Technology and the Harvard Program in Neuroscience. He earned a DPhil from Oxford via his work at the Oxford Centre for Neuroethics and the Ethox Center as a Rhodes Scholar. He holds an MSc in Neuroscience from Trinity College Dublin, where he studied as a Mitchell Scholar. He has also served as the student/post-doc representative to the board of the International Neuroethics Society.
Inhaltsangabe
* Introduction * Chapter 1: The Biomedical Promise Of Biomarkers * Chapter 2: Bioprediction Of Brain Disorder: Definitions And Scope * PART I: REORIENTATION OF THE CONCEPT OF DISORDER * Chapter 3:"There Is More Light Here." Re-Illuminating The Categories Of Mental * Chapter 4: The Probability Dysfunction * Chapter 5: The Practical Ethics Of Predictive Markers In Diagnosis: Can Risk Banding Address The Ethical Controversy Surrounding "Psychosis Risk Syndrome" And "Preclinical Alzheimer's Disease"? * PART II: BIOPREDICTION AND MORAL RESPONSIBILITY * Chapter 6: Enhanced Responsibility: Foreseeability And New Obligations To Others * Chapter 7: Reduced Responsibility: Distinguishing Conditions In Which Biomarkers Properly Reduce Legal Responsibility * PART III: BIOPREDICTION AND SOCIETY * Chapter 8: Bioprediction And Priority * Conclusion * Appendix I * Appendix II * Appendix III * References * Index
* Introduction * Chapter 1: The Biomedical Promise Of Biomarkers * Chapter 2: Bioprediction Of Brain Disorder: Definitions And Scope * PART I: REORIENTATION OF THE CONCEPT OF DISORDER * Chapter 3:"There Is More Light Here." Re-Illuminating The Categories Of Mental * Chapter 4: The Probability Dysfunction * Chapter 5: The Practical Ethics Of Predictive Markers In Diagnosis: Can Risk Banding Address The Ethical Controversy Surrounding "Psychosis Risk Syndrome" And "Preclinical Alzheimer's Disease"? * PART II: BIOPREDICTION AND MORAL RESPONSIBILITY * Chapter 6: Enhanced Responsibility: Foreseeability And New Obligations To Others * Chapter 7: Reduced Responsibility: Distinguishing Conditions In Which Biomarkers Properly Reduce Legal Responsibility * PART III: BIOPREDICTION AND SOCIETY * Chapter 8: Bioprediction And Priority * Conclusion * Appendix I * Appendix II * Appendix III * References * Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
